These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
271 related articles for article (PubMed ID: 23257933)
1. High vitreous concentration of IL-6 and IL-8, but not of adhesion molecules in relation to plasma concentrations in proliferative diabetic retinopathy. Koskela UE; Kuusisto SM; Nissinen AE; Savolainen MJ; Liinamaa MJ Ophthalmic Res; 2013; 49(2):108-14. PubMed ID: 23257933 [TBL] [Abstract][Full Text] [Related]
2. Assessment of selected adhesion molecule and proinflammatory cytokine levels in the vitreous body of patients with type 2 diabetes--role of the inflammatory-immune process in the pathogenesis of proliferative diabetic retinopathy. Adamiec-Mroczek J; Oficjalska-Młyńczak J Graefes Arch Clin Exp Ophthalmol; 2008 Dec; 246(12):1665-70. PubMed ID: 18682976 [TBL] [Abstract][Full Text] [Related]
3. Vascular adhesion molecules in vitreous from eyes with proliferative diabetic retinopathy. Limb GA; Hickman-Casey J; Hollifield RD; Chignell AH Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2453-7. PubMed ID: 10476819 [TBL] [Abstract][Full Text] [Related]
4. Increased vitreous concentrations of MCP-1 and IL-6 after vitrectomy in patients with proliferative diabetic retinopathy: possible association with postoperative macular oedema. Yoshida S; Kubo Y; Kobayashi Y; Zhou Y; Nakama T; Yamaguchi M; Tachibana T; Ishikawa K; Arita R; Nakao S; Sassa Y; Oshima Y; Kono T; Ishibashi T Br J Ophthalmol; 2015 Jul; 99(7):960-6. PubMed ID: 25631486 [TBL] [Abstract][Full Text] [Related]
5. Soluble cellular adhesion molecules in proliferative vitreoretinopathy and proliferative diabetic retinopathy. Barile GR; Chang SS; Park LS; Reppucci VS; Schiff WM; Schmidt AM Curr Eye Res; 1999 Sep; 19(3):219-27. PubMed ID: 10487959 [TBL] [Abstract][Full Text] [Related]
6. Elevated Levels of Cytokines Associated with Th2 and Th17 Cells in Vitreous Fluid of Proliferative Diabetic Retinopathy Patients. Takeuchi M; Sato T; Tanaka A; Muraoka T; Taguchi M; Sakurai Y; Karasawa Y; Ito M PLoS One; 2015; 10(9):e0137358. PubMed ID: 26352837 [TBL] [Abstract][Full Text] [Related]
7. Persistent secretion of vascular endothelial growth factor into the vitreous cavity in proliferative diabetic retinopathy after vitrectomy. Itakura H; Kishi S; Kotajima N; Murakami M Ophthalmology; 2004 Oct; 111(10):1880-4. PubMed ID: 15465550 [TBL] [Abstract][Full Text] [Related]
8. Interleukin-8, monocyte chemoattractant protein-1 and IL-10 in the vitreous fluid of patients with proliferative diabetic retinopathy. Hernández C; Segura RM; Fonollosa A; Carrasco E; Francisco G; Simó R Diabet Med; 2005 Jun; 22(6):719-22. PubMed ID: 15910622 [TBL] [Abstract][Full Text] [Related]
9. Vitreous and aqueous concentrations of proangiogenic, antiangiogenic factors and other cytokines in diabetic retinopathy patients with macular edema: Implications for structural differences in macular profiles. Patel JI; Tombran-Tink J; Hykin PG; Gregor ZJ; Cree IA Exp Eye Res; 2006 May; 82(5):798-806. PubMed ID: 16324700 [TBL] [Abstract][Full Text] [Related]
10. [Contribution of selected cellular adhesion molecules and proinflammatory cytokines in the pathogenesis of proliferative diabetic retinopathy]. Adamiec J; Oficjalska-Młyńczak J Przegl Lek; 2007; 64(6):389-92. PubMed ID: 18159844 [TBL] [Abstract][Full Text] [Related]
11. Elevated Activating Transcription Factor 4 and Glucose-Regulated 78 Kda Protein Levels Correlate with Inflammatory Cytokines in the Aqueous Humor and Vitreous of Proliferative Diabetic Retinopathy. Wang Y; Gao S; Zhu Y; Shen X Curr Eye Res; 2017 Aug; 42(8):1202-1208. PubMed ID: 28497987 [TBL] [Abstract][Full Text] [Related]
12. Soluble IL-6 receptor in vitreous fluid of patients with proliferative diabetic retinopathy. Kawashima M; Shoji J; Nakajima M; Kamura Y; Sato Y Jpn J Ophthalmol; 2007; 51(2):100-4. PubMed ID: 17401618 [TBL] [Abstract][Full Text] [Related]
13. Concentration of haemodynamic and inflammatory related cytokines in diabetic retinopathy. Patel JI; Saleh GM; Hykin PG; Gregor ZJ; Cree IA Eye (Lond); 2008 Feb; 22(2):223-8. PubMed ID: 17001327 [TBL] [Abstract][Full Text] [Related]
14. Interferon-induced protein 10 and interleukin 8. C-X-C chemokines present in proliferative diabetic retinopathy. Elner SG; Strieter R; Bian ZM; Kunkel S; Mokhtarzaden L; Johnson M; Lukacs N; Elner VM Arch Ophthalmol; 1998 Dec; 116(12):1597-601. PubMed ID: 9869787 [TBL] [Abstract][Full Text] [Related]
15. Vitreous levels of vascular endothelial growth factor and intercellular adhesion molecule 1 are related to diabetic macular edema. Funatsu H; Yamashita H; Sakata K; Noma H; Mimura T; Suzuki M; Eguchi S; Hori S Ophthalmology; 2005 May; 112(5):806-16. PubMed ID: 15878060 [TBL] [Abstract][Full Text] [Related]
16. Atrial natriuretic peptide in the vitreous humor and epiretinal membranes of patients with proliferative diabetic retinopathy. Rollin R; Mediero A; Martínez-Montero JC; Roldán-Pallarés M; Suárez-Leoz M; Vidal-Fernández P; Cortés-Valdés C; Fernández-Cruz A; Fernández-Durango R Mol Vis; 2004 Jul; 10():450-7. PubMed ID: 15273657 [TBL] [Abstract][Full Text] [Related]
17. High-mobility group box-1 and biomarkers of inflammation in the vitreous from patients with proliferative diabetic retinopathy. El-Asrar AM; Nawaz MI; Kangave D; Geboes K; Ola MS; Ahmad S; Al-Shabrawey M Mol Vis; 2011; 17():1829-38. PubMed ID: 21850157 [TBL] [Abstract][Full Text] [Related]
18. Lipopolysaccharide-binding protein and soluble CD14 in the vitreous fluid of patients with proliferative diabetic retinopathy. Hernández C; Ortega F; García-Ramírez M; Villarroel M; Casado J; García-Pascual L; Fernández-Real JM; Simó R Retina; 2010 Feb; 30(2):345-52. PubMed ID: 20175275 [TBL] [Abstract][Full Text] [Related]
19. Angiopoietin concentrations in diabetic retinopathy. Patel JI; Hykin PG; Gregor ZJ; Boulton M; Cree IA Br J Ophthalmol; 2005 Apr; 89(4):480-3. PubMed ID: 15774928 [TBL] [Abstract][Full Text] [Related]
20. Intraocular tumour necrosis factor ligand related molecule 1 A links disease progression of proliferative diabetic retinopathy after primary vitrectomy. Wang T; Li J; Xie R; Wang J; Zhang W; Jiang F; Du M; Wang X; Huang B; Brant R; Zhang C; Yan H Clin Exp Pharmacol Physiol; 2020 Jun; 47(6):966-976. PubMed ID: 32064668 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]